{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:34:55Z","timestamp":1771954495315,"version":"3.50.1"},"reference-count":61,"publisher":"Scientific Scholar","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol Venereol Leprol"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/ijdvl.ijdvl_1_17","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T11:41:44Z","timestamp":1522755704000},"page":"285","source":"Crossref","is-referenced-by-count":12,"title":["Association of interleukin 1 receptor antagonist intron 2 variable number of tandem repeats polymorphism with vitiligo susceptibility in Gujarat population"],"prefix":"10.25259","volume":"84","author":[{"given":"Rasheedunnisa","family":"Begum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mala","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MohmmadShoab","family":"Mansuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ShahnawazD","family":"Jadeja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YogeshS","family":"Marfatia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0378-6323.229171-1","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1365-4632.2011.05377.x","article-title":"A review of the worldwide prevalence of vitiligo in children\/adolescents and adults","author":"Kr\u00fcger","year":"2012","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0378-6323.229171-2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4103\/0378-6323.32708","article-title":"Vitiligo: Compendium of clinico-epidemiological features","author":"Sehgal","year":"2007","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0378-6323.229171-3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/exd.12103","article-title":"Vitiligo: Interplay between oxidative stress and immune system","author":"Laddha","year":"2013","journal-title":"Exp Dermatol"},{"key":"key-10.4103\/0378-6323.229171-4","first-page":"1","article-title":"Could ER stress be a major link between oxidative stress and autoimmunity in vitiligo?","author":"Mansuri","year":"2014","journal-title":"Pigment Disord"},{"key":"key-10.4103\/0378-6323.229171-5","first-page":"100","article-title":"Vitiligo: Clinical profiles in Vadodara, Gujarat","author":"Shajil","year":"2006","journal-title":"Indian J Dermatol","ISSN":"https:\/\/id.crossref.org\/issn\/0019-5154","issn-type":"print"},{"key":"key-10.4103\/0378-6323.229171-6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1034\/j.1600-0749.2003.00032.x","article-title":"Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families","author":"Alkhateeb","year":"2003","journal-title":"Pigment Cell Res"},{"key":"key-10.4103\/0378-6323.229171-7","doi-asserted-by":"crossref","first-page":"e52298","DOI":"10.1371\/journal.pone.0052298","article-title":"Increased tumor necrosis factor (TNF)-\u03b1 and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo","author":"Laddha","year":"2012","journal-title":"PLoS One"},{"key":"key-10.4103\/0378-6323.229171-8","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1365-2133.2012.11000.x","article-title":"Interleukin-4 genetic variants correlate with its transcript and protein levels in patients with vitiligo","author":"Imran","year":"2012","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.229171-9","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1089\/jir.2012.0171","article-title":"Involvement of interferon-gamma genetic variants and intercellular adhesion molecule-1 in onset and progression of generalized vitiligo","author":"Dwivedi","year":"2013","journal-title":"J Interferon Cytokine Res"},{"key":"key-10.4103\/0378-6323.229171-10","doi-asserted-by":"crossref","first-page":"e107020","DOI":"10.1371\/journal.pone.0107020","article-title":"Association of neuropeptide Y (NPY), interleukin-1B (IL1B) genetic variants and correlation of IL1B transcript levels with vitiligo susceptibility","author":"Laddha","year":"2014","journal-title":"PLoS One"},{"key":"key-10.4103\/0378-6323.229171-11","doi-asserted-by":"crossref","first-page":"e81736","DOI":"10.1371\/journal.pone.0081736","article-title":"Tumor necrosis factor B (TNFB) genetic variants and its increased expression are associated with vitiligo susceptibility","author":"Laddha","year":"2013","journal-title":"PLoS One"},{"key":"key-10.4103\/0378-6323.229171-12","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/exd.12372","article-title":"Role of oxidative stress and autoimmunity in onset and progression of vitiligo","author":"Laddha","year":"2014","journal-title":"Exp Dermatol"},{"key":"key-10.4103\/0378-6323.229171-13","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.freeradbiomed.2013.08.189","article-title":"Involvement of superoxide dismutase isoenzymes and their genetic variants in progression of and higher susceptibility to vitiligo","author":"Laddha","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"key-10.4103\/0378-6323.229171-14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1600-0749.2007.00406.x","article-title":"Association of catalase T\/C exon 9 and glutathione peroxidase codon 200 polymorphisms in relation to their activities and oxidative stress with vitiligo susceptibility in Gujarat population","author":"Em","year":"2007","journal-title":"Pigment Cell Res"},{"key":"key-10.4103\/0378-6323.229171-15","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/bjd.12467","article-title":"Association of NLRP1 genetic variants and mRNA overexpression with generalized vitiligo and disease activity in a Gujarat population","author":"Dwivedi","year":"2013","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.229171-16","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1755-148X.2011.00892.x","article-title":"Cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) in isolated vitiligo: A genotype-phenotype correlation","author":"Dwivedi","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"key":"key-10.4103\/0378-6323.229171-17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jdermsci.2013.04.026","article-title":"Correlation of increased MYG1 expression and its promoter polymorphism with disease progression and higher susceptibility in vitiligo patients","author":"Dwivedi","year":"2013","journal-title":"J Dermatol Sci"},{"key":"key-10.4103\/0378-6323.229171-18","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/exd.13007","article-title":"Genetic variations (Arg5Pro and leu6Pro) modulate the structure and activity of GPX1 and genetic risk for vitiligo","author":"Mansuri","year":"2016","journal-title":"Exp Dermatol"},{"key":"key-10.4103\/0378-6323.229171-19","doi-asserted-by":"crossref","first-page":"e0180958","DOI":"10.1371\/journal.pone.0180958","article-title":"Acase-control study on association of proteasome subunit beta 8 (PSMB8) and transporter associated with antigen processing 1 (TAP1) polymorphisms and their transcript levels in vitiligo from Gujarat","author":"Jadeja","year":"2017","journal-title":"PLoS One"},{"key":"key-10.4103\/0378-6323.229171-20","unstructured":"Mansuri MS, Jadeja SD, Singh M, Laddha NC, Dwivedi M, Begum R, et al. Catalase (CAT) promoter and 5'-UTR genetic variants lead to its altered expression and activity in vitiligo. Br J Dermatol 2017; doi: 10.1111\/bjd. 15681. [Epub ahead of print]."},{"key":"key-10.4103\/0378-6323.229171-21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nri702","article-title":"Cytokines and autoimmunity","author":"O'Shea","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"key-10.4103\/0378-6323.229171-22","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1073\/pnas.1304988111","article-title":"IFN-\u03b3 signaling maintains skin pigmentation homeostasis through regulation of melanosome maturation","author":"Natarajan","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/0378-6323.229171-23","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","author":"Dinarello","year":"2011","journal-title":"Blood"},{"key":"key-10.4103\/0378-6323.229171-24","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1074\/jbc.275.2.1169","article-title":"Four new members expand the interleukin-1 superfamily","author":"Smith","year":"2000","journal-title":"J Biol Chem"},{"key":"key-10.4103\/0378-6323.229171-25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1006\/geno.1993.1025","article-title":"The human interleukin-1 receptor antagonist (IL1RN) gene is located in the chromosome 2q14 region","author":"Patterson","year":"1993","journal-title":"Genomics"},{"key":"key-10.4103\/0378-6323.229171-26","doi-asserted-by":"crossref","first-page":"i60","DOI":"10.1136\/ard.59.suppl_1.i60","article-title":"Biological role of interleukin 1 receptor antagonist isoforms","author":"Arend","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"key-10.4103\/0378-6323.229171-27","doi-asserted-by":"crossref","first-page":"14147","DOI":"10.1016\/S0021-9258(18)98655-2","article-title":"Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor","author":"Granowitz","year":"1991","journal-title":"J Biol Chem"},{"key":"key-10.4103\/0378-6323.229171-28","first-page":"105","article-title":"Interleukin-1 (IL-1) pathway","author":"Weber","year":"2010","journal-title":"Sci Signal"},{"key":"key-10.4103\/0378-6323.229171-29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ni.2224","article-title":"Inflammasomes in carcinogenesis and anticancer immune responses","author":"Zitvogel","year":"2012","journal-title":"Nat Immunol"},{"key":"key-10.4103\/0378-6323.229171-30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jdermsci.2016.07.003","article-title":"MiRNA signatures and transcriptional regulation of their target genes in vitiligo","author":"Mansuri","year":"2016","journal-title":"J Dermatol Sci"},{"key":"key-10.4103\/0378-6323.229171-31","first-page":"403","article-title":"Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat","author":"Tarlow","year":"1993","journal-title":"Hum Genet"},{"key":"key-10.4103\/0378-6323.229171-32","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1002\/1521-4141(2002010)32:10<2988::AID-IMMU2988>3.0.CO;2-9","article-title":"Genetic control of IL-1beta bioactivity through differential regulation of the IL-1 receptor antagonist","author":"Vamvakopoulos","year":"2002","journal-title":"Eur J Immunol"},{"key":"key-10.4103\/0378-6323.229171-33","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1182\/blood.V79.9.2196.2196","article-title":"Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease","author":"Fischer","year":"1992","journal-title":"Blood"},{"key":"key-10.4103\/0378-6323.229171-34","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1084\/jem.173.4.931","article-title":"Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody","author":"McIntyre","year":"1991","journal-title":"J Exp Med"},{"key":"key-10.4103\/0378-6323.229171-35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1744-313X.2010.00975.x","article-title":"VNTR polymorphism of human IL1RN in Chinese Han and she ethnic populations","author":"Xu","year":"2011","journal-title":"Int J Immunogenet"},{"key":"key-10.4103\/0378-6323.229171-36","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1084\/jem.189.12.1863","article-title":"Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis","author":"Wilkinson","year":"1999","journal-title":"J Exp Med"},{"key":"key-10.4103\/0378-6323.229171-37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/08916934.2013.866101","article-title":"Polymorphisms in TSHR and IL1RN genes and the risk and prognosis of Hashimoto's thyroiditis","author":"Zaaber","year":"2014","journal-title":"Autoimmunity"},{"key":"key-10.4103\/0378-6323.229171-38","first-page":"126","article-title":"Association between IL4 (-590), ACE (I)\/(D), CCR5 (Delta32), CTLA4 (+49) and IL1-RN (VNTR in intron 2) gene polymorphisms and vitiligo","author":"Pehlivan","year":"2009","journal-title":"Eur J Dermatol"},{"key":"key-10.4103\/0378-6323.229171-39","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1755-148X.2012.00997.x","article-title":"Revised classification\/nomenclature of vitiligo and related issues: The vitiligo global issues consensus conference","author":"Ezzedine","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"key-10.4103\/0378-6323.229171-40","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0190-9622(95)90131-0","article-title":"The minigrafting test for vitiligo: Detection of stable lesions for melanocyte transplantation","author":"Falabella","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.229171-41","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1359-6101(02)00020-5","article-title":"The balance between IL-1 and IL-1Ra in disease","author":"Arend","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"key":"key-10.4103\/0378-6323.229171-42","first-page":"303","article-title":"Cytokine production by normal human monocytes: Inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism","author":"Danis","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"key-10.4103\/0378-6323.229171-43","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1046\/j.1365-2249.2000.01266.x","article-title":"Polymorphisms in the IL-1 receptor antagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies","author":"Rider","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"key-10.4103\/0378-6323.229171-44","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1002\/art.1780370917","article-title":"Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus","author":"Blakemore","year":"1994","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/0378-6323.229171-45","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0016-5085(94)90696-3","article-title":"Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist","author":"Mansfield","year":"1994","journal-title":"Gastroenterology"},{"key":"key-10.4103\/0378-6323.229171-46","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/1529-0131(200001)43:1<120::AID-ANR15>3.0.CO;2-3","article-title":"Systemic lupus erythematosus candidate genes in the Italian population: Evidence for a significant association with interleukin-10","author":"D'Alfonso","year":"2000","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/0378-6323.229171-47","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1086\/338261","article-title":"Influence of interleukin-1 receptor antagonist gene polymorphism on disease","author":"Witkin","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0378-6323.229171-48","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev.immunol.16.1.27","article-title":"Interleukin-1 receptor antagonist: Role in biology","author":"Arend","year":"1998","journal-title":"Annu Rev Immunol"},{"key":"key-10.4103\/0378-6323.229171-49","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/sj.gene.6364032","article-title":"Functional correlates of the interleukin-1 receptor antagonist gene polymorphism in the colonic mucosa in ulcerative colitis","author":"Carter","year":"2004","journal-title":"Genes Immun"},{"key":"key-10.4103\/0378-6323.229171-50","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.2337\/diab.43.10.1242","article-title":"Monokine antagonism is reduced in patients with IDDM","author":"Mandrup-Poulsen","year":"1994","journal-title":"Diabetes"},{"key":"key-10.4103\/0378-6323.229171-51","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/j.1365-4632.2006.02744.x","article-title":"Increased tumor necrosis factor alpha (TNF-alpha) and interleukin 1 alpha (IL1-alpha) levels in the lesional skin of patients with nonsegmental vitiligo","author":"Birol","year":"2006","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0378-6323.229171-52","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1161\/01.ATV.20.11.2394","article-title":"Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis","author":"Dewberry","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key-10.4103\/0378-6323.229171-53","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/BF02346180","article-title":"Novel interleukin-1 receptor antagonist exon polymorphisms and their use in allele-specific mRNA assessment","author":"Clay","year":"1996","journal-title":"Hum Genet"},{"key":"key-10.4103\/0378-6323.229171-54","doi-asserted-by":"crossref","first-page":"299","DOI":"10.5021\/ad.1995.7.4.299","article-title":"Polymorphism in the IL-1 receptor antagonist gene in vitiligo","author":"Lee","year":"1995","journal-title":"Ann Dermatol"},{"key":"key-10.4103\/0378-6323.229171-55","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1365-3083.1998.00300.x","article-title":"Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro","author":"Santtila","year":"1998","journal-title":"Scand J Immunol"},{"key":"key-10.4103\/0378-6323.229171-56","first-page":"273","article-title":"Interleukin 1-\u03b1: A modulator of melanocyte homeostasis in vitiligo","author":"Singh","year":"2016","journal-title":"Biochem Anal Biochem"},{"key":"key-10.4103\/0378-6323.229171-57","doi-asserted-by":"crossref","first-page":"P39","DOI":"10.1186\/1471-2164-15-S2-P39","article-title":"In vitro effect of immune regulatory cytokines on vitiligo pathogenesis","author":"Singh","year":"2014","journal-title":"BMC Genomics"},{"key":"key-10.4103\/0378-6323.229171-58","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/sj.tpj.6500396","article-title":"Pharmacogenetic of antirheumatic treatments: Clinical implications","author":"Ferraccioli","year":"2007","journal-title":"Pharmacogenomics J"},{"key":"key-10.4103\/0378-6323.229171-59","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1517\/14712598.1.2.301","article-title":"Interleukin-1 receptor antagonist as therapy for inflammatory disorders","author":"Freeman","year":"2001","journal-title":"Expert Opin Biol Ther"},{"key":"key-10.4103\/0378-6323.229171-60","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/ard.61.11.960","article-title":"Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases","author":"Hallegua","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"key-10.4103\/0378-6323.229171-61","first-page":"454","article-title":"Interleukin-1 receptor antagonist gene therapy for arthritis","author":"Krishnan","year":"1999","journal-title":"Curr Opin Mol Ther"}],"container-title":["Indian Journal of Dermatology, Venereology and Leprology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T10:42:45Z","timestamp":1611916965000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijdvl.com\/association-of-interleukin-1-receptor-antagonist-intron-2-variable-number-of-tandem-repeats-polymorphism-with-vitiligo-susceptibility-in-gujarat-population\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"alternative-id":["229171"],"URL":"https:\/\/doi.org\/10.4103\/ijdvl.ijdvl_1_17","relation":{},"ISSN":["0378-6323"],"issn-type":[{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}